Product Information
SYNTHROID 300 MCG TABLET is a brand product labeled by AbbVie Inc., priced at $1.6599 per EA under NDC 00074714990. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
300 ug/1
Manufacturer
AbbVie Inc.NDC
00074714990
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LEVOTHYROXINE SODIUMApproval Type
New Drug (NDA)
FDA Application
NDA021402On Market Since
7/24/2002
Pharmacological Classes
Price Statistics
The NADAC for SYNTHROID 300 MCG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 42.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.6599 per EA |
|---|---|
| All-time high | $1.6599 (Jun 24, 2026) |
| All-time low | $1.1296 (Nov 19, 2014) |
| 52-week high | $1.6599 |
| 52-week low | $1.5749 |
| Median price | $1.2338 |
| Average price | $1.3001 |
| Largest weekly change | +5.0% (Jan 10, 2024) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 93% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of SYNTHROID 300 MCG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SYNTHROID 300 MCG TABLET, manufactured by AbbVie Inc., is $1.6599 per EA (NDC 00074714990), effective Jun 24, 2026.
How has the price of SYNTHROID 300 MCG TABLET changed over time?
Over the history we have for it, the NADAC for SYNTHROID 300 MCG TABLET has risen 42.6%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for SYNTHROID 300 MCG TABLET?
Since Nov 28, 2013, the NADAC for SYNTHROID 300 MCG TABLET has ranged from a low of $1.1296 (Nov 19, 2014) to a high of $1.6599 (Jun 24, 2026), with a median of $1.2338 per EA.
Are there cheaper alternatives to SYNTHROID 300 MCG TABLET?
Yes. 4 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, LEVOTHYROXINE 300 MCG TABLET, is $0.1084 per EA — about 93% below SYNTHROID 300 MCG TABLET.
Who manufactures SYNTHROID 300 MCG TABLET?
SYNTHROID 300 MCG TABLET (NDC 00074714990) is labeled by AbbVie Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification